Wells Fargo
ASMB icon

Wells Fargo’s Assembly Biosciences ASMB Stock Holding History

Wells Fargo’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-145
Closed -$3.71K – 7111
2025
Q3 		$3.71K Hold
145
– – ﹤0.01% 6112
2025
Q2 		$2.63K Hold
145
– – ﹤0.01% 6179
2025
Q1 		$1.39K Buy
+145
New +$1.9K ﹤0.01% 6200
2024
Q2 		– Sell
-44
Closed -$585 – 6903
2024
Q1 		$585 Buy
44
+2
+5% +$23 ﹤0.01% 6252
2023
Q4 		$415 Buy
42
+10
+31% +$95 ﹤0.01% 6428
2023
Q3 		$340 Buy
32
+1
+3% +$12 ﹤0.01% 6444
2023
Q2 		$431 Buy
31
+3
+11% +$37 ﹤0.01% 6524
2023
Q1 		$283 Hold
28
– – ﹤0.01% 6681
2022
Q4 		$432 Buy
28
+1
+4% +$17 ﹤0.01% 6423
2022
Q3 		$1K Buy
27
+3
+13% +$73 ﹤0.01% 6265
2022
Q2 		$1K Buy
24
+2
+9% +$46 ﹤0.01% 6456
2022
Q1 		$1K Hold
22
– – ﹤0.01% 6748
2021
Q4 		$1K Buy
22
+11
+100% +$361 ﹤0.01% 6956
2021
Q3 		$0 Sell
11
-10,277
-100% -$431K ﹤0.01% 6945
2021
Q2 		$479K Buy
10,288
+9,630
+1,464% +$477K ﹤0.01% 4640
2021
Q1 		$37K Sell
658
-5,838
-90% -$387K ﹤0.01% 5943
2020
Q4 		$472K Buy
6,496
+1,410
+28% +$165K ﹤0.01% 4563
2020
Q3 		$1M Sell
5,086
-673
-12% -$169K ﹤0.01% 3861
2020
Q2 		$1.61M Buy
5,759
+2,499
+77% +$583K ﹤0.01% 3431
2020
Q1 		$580K Sell
3,260
-151
-4% -$32.4K ﹤0.01% 3933
2019
Q4 		$837K Buy
3,411
+2,274
+200% +$419K ﹤0.01% 3983
2019
Q3 		$134K Buy
1,137
+86
+8% +$13K ﹤0.01% 5183
2019
Q2 		$170K Sell
1,051
-175
-14% -$33.3K ﹤0.01% 5060
2019
Q1 		$290K Sell
1,226
-1,872
-60% -$474K ﹤0.01% 4637
2018
Q4 		$840K Sell
3,098
-2,272
-42% -$657K ﹤0.01% 3972
2018
Q3 		$2.39M Buy
5,370
+831
+18% +$389K ﹤0.01% 3263
2018
Q2 		$2.13M Buy
4,539
+3,790
+506% +$2M ﹤0.01% 3408
2018
Q1 		$442K Buy
749
+74
+11% +$45.9K ﹤0.01% 4482
2017
Q4 		$367K Sell
675
-1,458
-68% -$660K ﹤0.01% 4613
2017
Q3 		$894K Buy
2,133
+1,275
+149% +$391K ﹤0.01% 3930
2017
Q2 		$213K Buy
+858
New +$242K ﹤0.01% 4742
2016
Q2 		– Sell
-190
Closed -$11K – 6083
2016
Q1 		$11K Buy
190
+69
+57% +$4.61K ﹤0.01% 5661
2015
Q4 		$11K Buy
121
+115
+1,917% +$12.5K ﹤0.01% 5712
2015
Q3 		$1K Sell
6
-54
-90% -$9.5K ﹤0.01% 6045
2015
Q2 		$14K Sell
60
-190
-76% -$36.7K ﹤0.01% 5708
2015
Q1 		$40K Buy
+250
New +$33.8K ﹤0.01% 5105
2014
Q4 		– Sell
-8
Closed -$1K – 6201
2014
Q3 		$1K Hold
8
– – ﹤0.01% 6057
2014
Q2 		$1K Hold
8
– – ﹤0.01% 5991
2014
Q1 		$1K Sell
8
-25
-76% -$3.89K ﹤0.01% 5752
2013
Q4 		$8K Buy
33
+16
+94% +$2.91K ﹤0.01% 5239
2013
Q3 		$3K Buy
+17
New +$2.6K ﹤0.01% 5376

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Wells Fargo's ASMB Position: Q4 2025 in Review

Wells Fargo sold out of Assembly Biosciences (ASMB) in Q4 2025, closing a stake of 145 shares — an estimated $3.71K sold.

Wells Fargo first reported a position in ASMB in Q3 2013 and held it in 41 quarters. The position peaked at $2.39M in Q3 2018. 69 funds tracked by Wall St. Rank hold ASMB as of Q4 2025.

  • Wells Fargo reported no remaining Assembly Biosciences position as of Q4 2025 after selling out during the quarter.
  • Wells Fargo sold 145 Assembly Biosciences shares in Q4 2025, an estimated $3.71K.
  • Wells Fargo first reported a position in Assembly Biosciences in Q3 2013 and held it in 41 quarters.
  • Wells Fargo's Assembly Biosciences position peaked at $2.39M in Q3 2018.
  • 69 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2025.

Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.